ETSY Etsy | $59.24 -15.1% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $80.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 5/2/2024 |
FSLR First Solar | $180.51 +1.6% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $359.00 -> $356.00 | Low | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/2/2024 |
MCD McDonald's | $273.28 -0.4% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $325.00 -> $315.00 | Low | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 5/2/2024 |
NBIX Neurocrine Biosciences | $139.83 -2.2% | 5/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $164.00 -> $170.00 | Low | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
DCPH Deciphera Pharmaceuticals | $25.38 +0.1% | 4/30/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 4/30/2024 |
DTIL Precision BioSciences | $10.84 +3.4% | 4/30/2024 | Initiated by | Guggenheim | - | Buy | $19.00 | Low | View details for Guggenheim rating of Precision BioSciences (NASDAQ:DTIL) on 4/30/2024 |
|
ABVX ABIVAX Société Anonyme | $14.92 -0.8% | 4/29/2024 | Initiated by | Guggenheim | - | Buy | $50.00 | Low | View details for Guggenheim rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 4/29/2024 |
ALT Altimmune | $7.19 +1.7% | 4/29/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Altimmune (NASDAQ:ALT) on 4/29/2024 |
META Meta Platforms | $441.68 +0.6% | 4/25/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $520.00 -> $500.00 | N/A | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
SPOT Spotify Technology | $294.35 +3.4% | 4/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $290.00 -> $350.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 4/24/2024 |
MEDP Medpace | $391.07 -1.7% | 4/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $453.00 -> $464.00 | Low | View details for Guggenheim rating of Medpace (NASDAQ:MEDP) on 4/24/2024 |
ENPH Enphase Energy | $106.06 +0.9% | 4/24/2024 | Downgraded by | Guggenheim | - | Neutral -> Sell | $92.00 | Low | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
ANIP ANI Pharmaceuticals | $67.11 +0.9% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $77.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/23/2024 |
IMCR Immunocore | $59.46 +0.7% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $92.00 | Low | View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 4/23/2024 |
INFA Informatica | $30.31 -1.8% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $37.00 | Low | View details for Guggenheim rating of Informatica (NYSE:INFA) on 4/23/2024 |
TSLA Tesla | $180.01 +0.0% | 4/23/2024 | Reiterated by | Guggenheim | - | Sell -> Sell | $122.00 -> $122.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 4/23/2024 |
NXT Nextracker | $43.68 +1.9% | 4/23/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $73.00 -> $60.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 4/23/2024 |
SBUX Starbucks | $74.93 +0.7% | 4/19/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $100.00 -> $91.00 | Low | View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
VRTX Vertex Pharmaceuticals | $400.16 -0.5% | 4/18/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $445.00 -> $450.00 | Low | View details for Guggenheim rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/18/2024 |
AN AutoNation | $163.26 +0.3% | 4/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $165.00 -> $169.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 4/17/2024 |
APTV Aptiv | $77.79 +11.5% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $103.00 -> $92.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 4/17/2024 |
GNTX Gentex | $34.13 +0.5% | 4/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $40.00 -> $41.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 4/17/2024 |
LAD Lithia Motors | $251.20 -1.2% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $320.00 -> $297.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 4/17/2024 |
VC Visteon | $115.29 +2.7% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $136.00 -> $126.00 | N/A | View details for Guggenheim rating of Visteon (NASDAQ:VC) on 4/17/2024 |
GPI Group 1 Automotive | $292.53 -0.4% | 4/17/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $305.00 | Low | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 4/17/2024 |
NFLX Netflix | $565.15 +2.4% | 4/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $600.00 -> $700.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/16/2024 |
NOW ServiceNow | $695.72 +1.5% | 4/15/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/15/2024 |
IMNM Immunome | $14.97 +1.9% | 4/15/2024 | Initiated by | Guggenheim | - | Buy | $35.00 | Low | View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 4/15/2024 |
ENGN enGene | $15.32 -3.6% | 4/15/2024 | Initiated by | Guggenheim | - | Buy | $34.00 | Low | View details for Guggenheim rating of enGene (NASDAQ:ENGN) on 4/15/2024 |
ALPN Alpine Immune Sciences | $64.60
| 4/9/2024 | Initiated by | Guggenheim | - | Buy | $55.00 | Low | View details for Guggenheim rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/9/2024 |
VERA Vera Therapeutics | $43.50 +2.8% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $56.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 4/5/2024 |
WMG Warner Music Group | $33.22 -0.6% | 4/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $46.00 -> $45.00 | Low | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 4/5/2024 |
RCM R1 RCM | $12.45 +0.7% | 4/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $15.00 | Low | View details for Guggenheim rating of R1 RCM (NASDAQ:RCM) on 4/5/2024 |
ARRY Array Technologies | $13.06 +4.8% | 4/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $20.00 -> $22.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 4/5/2024 |
BROS Dutch Bros | $26.92 -0.3% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | $30.00 | Low | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 4/5/2024 |
ADCT ADC Therapeutics | $4.73 +0.4% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy | | Low | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 4/5/2024 |
CVAC CureVac | $2.77 +4.5% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of CureVac (NASDAQ:CVAC) on 4/5/2024 |
GH Guardant Health | $18.58 +1.8% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 4/5/2024 |
HD Home Depot | $335.53 +1.1% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $390.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 4/5/2024 |
IVVD Invivyd | $2.37 -2.1% | 4/5/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $9.00 | Low | View details for Guggenheim rating of Invivyd (NASDAQ:IVVD) on 4/5/2024 |
Could Your Accounts Be Frozen? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
PRKS United Parks & Resorts | $49.84 +1.9% | 4/4/2024 | Initiated by | Guggenheim | - | Buy | $73.00 | Low | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 4/4/2024 |
DIS Walt Disney | $112.62 +1.9% | 4/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | Low | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 4/3/2024 |
EDR Endeavor Group | $26.50 +0.3% | 4/3/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | $36.00 -> $27.50 | Low | View details for Guggenheim rating of Endeavor Group (NYSE:EDR) on 4/3/2024 |
PVH PVH | $110.56 +0.8% | 4/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $120.00 -> $140.00 | Low | View details for Guggenheim rating of PVH (NYSE:PVH) on 4/2/2024 |
ADCT ADC Therapeutics | $4.73 +0.4% | 3/28/2024 | Initiated by | Guggenheim | - | Buy | $11.00 | Low | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/28/2024 |
VERA Vera Therapeutics | $43.50 +2.8% | 3/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $27.00 -> $56.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 3/27/2024 |
TVTX Travere Therapeutics | $6.16 +2.7% | 3/27/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 3/27/2024 |
VYGR Voyager Therapeutics | $8.53 +2.0% | 3/26/2024 | Initiated by | Guggenheim | - | Buy | $22.00 | Low | View details for Guggenheim rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/26/2024 |
VALN Valneva | $7.43 -1.9% | 3/22/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $18.00 -> $17.00 | Low | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/22/2024 |
ABBV AbbVie | $160.85 -0.5% | 3/22/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $188.00 -> $190.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 3/22/2024 |
LULU Lululemon Athletica | $350.80 -1.0% | 3/22/2024 | Target Lowered by | Guggenheim | - | Buy | $550.00 -> $525.00 | Low | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
TSQ Townsquare Media | $12.47 +4.4% | 3/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $12.00 -> $12.50 | Low | View details for Guggenheim rating of Townsquare Media (NYSE:TSQ) on 3/20/2024 |
TIXT TELUS International (Cda) | $8.12 -1.8% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $9.00 | Low | View details for Guggenheim rating of TELUS International (Cda) (NYSE:TIXT) on 3/19/2024 |
TASK TaskUs | $11.94 +0.1% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $13.00 | Low | View details for Guggenheim rating of TaskUs (NASDAQ:TASK) on 3/19/2024 |
DXC DXC Technology | $18.90 -0.5% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $22.00 | Low | View details for Guggenheim rating of DXC Technology (NYSE:DXC) on 3/19/2024 |
TTEC TTEC | $7.53 +3.2% | 3/19/2024 | Initiated by | Guggenheim | - | Sell | $8.00 | Low | View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 3/19/2024 |
PRFT Perficient | $48.85 +3.4% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $65.00 | Low | View details for Guggenheim rating of Perficient (NASDAQ:PRFT) on 3/19/2024 |
GLOB Globant | $179.58 +0.9% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $250.00 | Low | View details for Guggenheim rating of Globant (NYSE:GLOB) on 3/19/2024 |
DAVA Endava | $31.14 -0.4% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $60.00 | Low | View details for Guggenheim rating of Endava (NYSE:DAVA) on 3/19/2024 |
DRI Darden Restaurants | $147.86 -2.2% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $180.00 -> $185.00 | Low | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/19/2024 |
GNTX Gentex | $34.13 +0.5% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/19/2024 |
KR Kroger | $55.09 +0.6% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $61.00 | Low | View details for Guggenheim rating of Kroger (NYSE:KR) on 3/19/2024 |
ACN Accenture | $300.30 +0.5% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $425.00 | Low | View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/19/2024 |
INFY Infosys | $16.88 +0.7% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $20.00 | Low | View details for Guggenheim rating of Infosys (NYSE:INFY) on 3/19/2024 |
CTSH Cognizant Technology Solutions | $66.27 +1.4% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $80.00 | Low | View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 3/19/2024 |
EPAM EPAM Systems | $238.18 +1.4% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $350.00 | Low | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 3/19/2024 |
IMRX Immuneering | $1.56 +2.0% | 3/14/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Immuneering (NASDAQ:IMRX) on 3/14/2024 |
WW WW International | $1.89 +3.3% | 3/18/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.00 | Low | View details for Guggenheim rating of WW International (NASDAQ:WW) on 3/18/2024 |
SNOW Snowflake | $157.77 +1.0% | 3/15/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | | Low | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 3/15/2024 |
SIRI Sirius XM | $3.05
| 3/14/2024 | Initiated by | Guggenheim | - | Neutral | $4.00 | Low | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 3/14/2024 |
SPRB Spruce Biosciences | $0.74 +2.8% | 3/14/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024 |
FL Foot Locker | $21.46 +4.2% | 3/7/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $30.00 | Low | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 3/7/2024 |
EOSE Eos Energy Enterprises | $0.69 +6.1% | 3/7/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $4.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/7/2024 |
YUM Yum! Brands | $135.02 -0.2% | 3/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $145.00 -> $155.00 | Low | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 3/7/2024 |
BASE Couchbase | $25.17 +3.9% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $27.00 -> $32.00 | Low | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $303.54 +2.7% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $358.00 -> $424.00 | N/A | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
ROST Ross Stores | $127.68 -0.1% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $140.00 -> $165.00 | Low | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 3/6/2024 |
TGT Target | $158.12 +1.1% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $160.00 -> $190.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 3/6/2024 |
ANIP ANI Pharmaceuticals | $67.11 +0.9% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $77.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2024 |
PRME Prime Medicine | $5.61 +6.5% | 3/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $24.00 -> $20.00 | Low | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 3/5/2024 |
APGE Apogee Therapeutics | $52.20 +2.5% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $44.00 -> $91.00 | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024 |
DLTR Dollar Tree | $119.78 +1.0% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $155.00 -> $170.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/5/2024 |
IHRT iHeartMedia | $2.23 +3.7% | 3/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/4/2024 |
MDB MongoDB | $363.17 -2.7% | 3/4/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $250.00 -> $272.00 | Low | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 3/4/2024 |
D Dominion Energy | $51.16 +0.0% | 3/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $57.00 -> $52.00 | Low | View details for Guggenheim rating of Dominion Energy (NYSE:D) on 3/4/2024 |
GSK GSK | $43.35 +1.8% | 3/4/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of GSK (NYSE:GSK) on 3/4/2024 |
AMRC Ameresco | $21.47 +4.8% | 2/29/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Ameresco (NYSE:AMRC) on 2/29/2024 |
MRSN Mersana Therapeutics | $3.36 -0.3% | 2/29/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $7.00 | Low | View details for Guggenheim rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
NUVL Nuvalent | $72.49 +2.6% | 2/28/2024 | Initiated by | Guggenheim | - | Buy | $99.00 | Low | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 2/28/2024 |
INSM Insmed | $25.66 +0.3% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $54.00 | Low | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/27/2024 |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
KRYS Krystal Biotech | $160.23 +0.4% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $175.00 | Low | View details for Guggenheim rating of Krystal Biotech (NASDAQ:KRYS) on 2/27/2024 |
WDAY Workday | $250.85 +2.4% | 2/27/2024 | Reiterated by | Guggenheim | - | Sell -> Sell | $190.00 | Low | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/27/2024 |
BGNE BeiGene | $162.01 +3.5% | 2/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $350.00 -> $345.00 | Low | View details for Guggenheim rating of BeiGene (NASDAQ:BGNE) on 2/27/2024 |
CLDX Celldex Therapeutics | $40.86 +3.8% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $90.00 | Low | View details for Guggenheim rating of Celldex Therapeutics (NASDAQ:CLDX) on 2/27/2024 |
HIMS Hims & Hers Health | $12.25 -2.1% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $15.00 -> $17.00 | Low | View details for Guggenheim rating of Hims & Hers Health (NYSE:HIMS) on 2/27/2024 |
FND Floor & Decor | $112.80 +3.2% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $115.00 -> $130.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 2/27/2024 |
PFE Pfizer | $27.70 +1.9% | 2/23/2024 | Initiated by | Guggenheim | - | Buy | $36.00 | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/23/2024 |
AXSM Axsome Therapeutics | $74.19 -0.9% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $125.00 | Low | View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/21/2024 |
CNP CenterPoint Energy | $29.40 +0.3% | 2/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $33.00 -> $32.00 | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 2/21/2024 |
CRWD CrowdStrike | $303.54 +2.7% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $274.00 -> $358.00 | Low | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 2/21/2024 |
HD Home Depot | $335.53 +1.1% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $370.00 -> $390.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/21/2024 |
S SentinelOne | $21.50 +0.2% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $26.00 -> $32.00 | Low | View details for Guggenheim rating of SentinelOne (NYSE:S) on 2/21/2024 |
SPRB Spruce Biosciences | $0.74 +2.8% | 2/21/2024 | Initiated by | Guggenheim | - | Buy | $10.00 | Low | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 2/21/2024 |
BTSG BrightSpring Health Services | $11.06 +3.8% | 2/20/2024 | Initiated by | Guggenheim | - | Buy | $15.00 | Low | View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024 |
SPWR SunPower | $2.18 +4.8% | 2/16/2024 | Downgraded by | Guggenheim | - | Neutral -> Sell | | Low | View details for Guggenheim rating of SunPower (NASDAQ:SPWR) on 2/16/2024 |
CRL Charles River Laboratories International | $229.89 -1.2% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Charles River Laboratories International (NYSE:CRL) on 2/15/2024 |
IQV IQVIA | $222.14 -4.6% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of IQVIA (NYSE:IQV) on 2/15/2024 |
GNRC Generac | $128.66 +0.8% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 2/15/2024 |
QSR Restaurant Brands International | $74.21 +1.4% | 2/14/2024 | Target Raised by | Guggenheim | - | Neutral | $70.00 -> $74.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 2/14/2024 |
NXT Nextracker | $43.68 +1.9% | 2/8/2024 | Initiated by | Guggenheim | - | Buy | $73.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 2/8/2024 |
SWTX SpringWorks Therapeutics | $43.35 -7.5% | 2/5/2024 | Initiated by | Guggenheim | - | Buy | $75.00 | Low | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/5/2024 |
SN SharkNinja | 65.12 +1.6% | 2/5/2024 | Initiated by | Guggenheim | - | Buy | 60.00 | Low | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 2/5/2024 |
APTV Aptiv | $77.79 +11.5% | 2/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $103.00 | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 2/2/2024 |
TSCO Tractor Supply | $266.70 -1.6% | 2/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $210.00 -> $255.00 | Low | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024 |
META Meta Platforms | $441.68 +0.6% | 2/2/2024 | Target Raised by | Guggenheim | - | Buy | $380.00 -> $520.00 | Low | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
CMS CMS Energy | $61.27 +0.7% | 2/2/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $60.00 -> $64.00 | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/2/2024 |
HCAT Health Catalyst | $6.54 +3.6% | 1/26/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $14.00 | Low | View details for Guggenheim rating of Health Catalyst (NASDAQ:HCAT) on 1/26/2024 |
OTLK Outlook Therapeutics | $8.50
| 1/25/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $40.00 | Low | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/25/2024 |
NFLX Netflix | $565.15 +2.4% | 1/24/2024 | Target Raised by | Guggenheim | - | Buy | $500.00 -> $600.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/24/2024 |
NEE NextEra Energy | $68.86 +0.4% | 1/22/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $80.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 1/22/2024 |
PEG Public Service Enterprise Group | $70.02 +0.3% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $61.00 | Low | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 1/22/2024 |
IDA IDACORP | $95.39 -0.6% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $93.00 | Low | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/22/2024 |
PNW Pinnacle West Capital | $75.04 +0.1% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $78.00 | Low | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 1/22/2024 |
NWE NorthWestern Energy Group | $51.00 +0.3% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $47.00 | Low | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/22/2024 |
EVRG Evergy | $53.55 +1.2% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $52.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 1/22/2024 |
DTE DTE Energy | $111.91 +0.5% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $111.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/22/2024 |
AEP American Electric Power | $88.25 +0.1% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $81.00 | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/22/2024 |
ES Eversource Energy | $60.75 -1.4% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $60.00 -> $72.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 1/22/2024 |
EIX Edison International | $71.97 +1.0% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $66.00 -> $84.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/22/2024 |
AVA Avista | $36.79 +0.4% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $34.00 | Low | View details for Guggenheim rating of Avista (NYSE:AVA) on 1/22/2024 |
ALE ALLETE | $60.87 +0.9% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $58.00 | Low | View details for Guggenheim rating of ALLETE (NYSE:ALE) on 1/22/2024 |
NAMS NewAmsterdam Pharma | $22.57 +2.7% | 1/18/2024 | Initiated by | Guggenheim | - | Buy | $30.00 | Low | View details for Guggenheim rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 1/18/2024 |
ALLO Allogene Therapeutics | $2.97 +1.7% | 1/5/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Allogene Therapeutics (NASDAQ:ALLO) on 1/5/2024 |
APGE Apogee Therapeutics | $52.20 +2.5% | 1/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $29.00 -> $44.00 | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 1/3/2024 |
LBPH Longboard Pharmaceuticals | $22.81 +3.9% | 1/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $16.00 -> $32.00 | Low | View details for Guggenheim rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/2/2024 |
KRTX Karuna Therapeutics | $329.83
| 12/22/2023 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023 |
WW WW International | $1.89 +3.3% | 12/20/2023 | Initiated by | Guggenheim | - | Buy | $14.00 | Low | View details for Guggenheim rating of WW International (NASDAQ:WW) on 12/20/2023 |
SNAP Snap | $16.30 +2.8% | 12/18/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $9.00 -> $23.00 | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/18/2023 |
ETSY Etsy | $59.24 -15.1% | 12/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $95.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 12/15/2023 |
TSLA Tesla | $180.01 +0.0% | 12/15/2023 | Target Raised by | Guggenheim | - | Sell -> Sell | $125.00 -> $132.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/15/2023 |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
EXC Exelon | $37.89 +0.1% | 12/15/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | $44.00 -> $40.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 12/15/2023 |
PACB Pacific Biosciences of California | $1.76 +4.1% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Pacific Biosciences of California (NASDAQ:PACB) on 12/14/2023 |
NTRA Natera | $93.72 -0.5% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $70.00 | Low | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 12/14/2023 |
TXG 10x Genomics | $26.29 -2.3% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $60.00 | Low | View details for Guggenheim rating of 10x Genomics (NASDAQ:TXG) on 12/14/2023 |
MYGN Myriad Genetics | $19.22 -1.3% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $23.00 | Low | View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 12/14/2023 |
ILMN Illumina | $123.99 -0.6% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $155.00 | Low | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 12/14/2023 |
GH Guardant Health | $18.58 +1.8% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 12/14/2023 |
EXAS Exact Sciences | $60.54 +0.9% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $90.00 | Low | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 12/14/2023 |
CSTL Castle Biosciences | $22.84 +3.7% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $25.00 | Low | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 12/14/2023 |
AKYA Akoya Biosciences | $3.99 +0.8% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Akoya Biosciences (NASDAQ:AKYA) on 12/14/2023 |
SYRE Spyre Therapeutics | $36.27 +7.1% | 12/11/2023 | Initiated by | Guggenheim | - | Buy | $44.00 | Low | View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/11/2023 |
PSTG Pure Storage | $51.42 +2.6% | 12/7/2023 | Initiated by | Guggenheim | - | Buy | $48.00 | Low | View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 12/7/2023 |
NEE NextEra Energy | $68.86 +0.4% | 12/6/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $65.00 -> $70.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 12/6/2023 |
NEP NextEra Energy Partners | $29.60 +3.5% | 12/6/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $42.00 -> $37.00 | Low | View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 12/6/2023 |
SPHR Sphere Entertainment | $40.38 +2.3% | 12/6/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 12/6/2023 |
INCY Incyte | $53.09 +0.3% | 12/4/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $86.00 | Low | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 12/4/2023 |
SLNO Soleno Therapeutics | $49.23 +3.6% | 11/21/2023 | Reiterated by | Guggenheim | - | Buy | $40.00 | Low | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 11/21/2023 |
ARVN Arvinas | $32.43 -0.2% | 11/20/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $40.00 | Low | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 11/20/2023 |
BWA BorgWarner | $35.63 +8.4% | 11/16/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $41.00 | Low | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 11/16/2023 |
DKNG DraftKings | $43.03 +2.9% | 11/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $39.00 -> $45.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 11/15/2023 |
HD Home Depot | $335.53 +1.1% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $360.00 -> $340.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 11/15/2023 |
HLVX HilleVax | $14.02 +3.4% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $38.00 -> $34.00 | Low | View details for Guggenheim rating of HilleVax (NASDAQ:HLVX) on 11/15/2023 |
MLTX MoonLake Immunotherapeutics | $42.57 -0.6% | 11/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $77.00 | Low | View details for Guggenheim rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/15/2023 |
ROIV Roivant Sciences | $11.24 +0.3% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $16.00 | Low | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 11/15/2023 |
XPOF Xponential Fitness | $13.43 +3.2% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $30.00 -> $25.00 | Low | View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 11/15/2023 |
ARRY Array Technologies | $13.06 +4.8% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $36.00 -> $30.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/8/2023 |
IDYA IDEAYA Biosciences | $41.49 +0.8% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $48.00 -> $44.00 | Low | View details for Guggenheim rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/8/2023 |
TKO TKO Group | $95.33 -0.4% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $126.00 -> $120.00 | Low | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 11/8/2023 |
XNCR Xencor | $23.63 -1.3% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $40.00 -> $34.00 | Low | View details for Guggenheim rating of Xencor (NASDAQ:XNCR) on 11/8/2023 |
MGNX MacroGenics | $15.22 -2.1% | 11/7/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $12.00 | Low | View details for Guggenheim rating of MacroGenics (NASDAQ:MGNX) on 11/7/2023 |
SVRA Savara | $4.68 -5.5% | 11/7/2023 | Initiated by | Guggenheim | - | Buy | $7.00 | Low | View details for Guggenheim rating of Savara (NASDAQ:SVRA) on 11/7/2023 |
UTL Unitil | $52.41 -0.6% | 11/6/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Unitil (NYSE:UTL) on 11/6/2023 |
DTE DTE Energy | $111.91 +0.5% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $103.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 11/3/2023 |
EIX Edison International | $71.97 +1.0% | 11/3/2023 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $63.00 -> $66.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 11/3/2023 |
ETR Entergy | $107.16 +0.2% | 11/3/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $99.00 -> $103.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/3/2023 |
ETSY Etsy | $59.24 -15.1% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $75.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 11/3/2023 |
IQV IQVIA | $222.14 -4.6% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $253.00 -> $220.00 | Low | View details for Guggenheim rating of IQVIA (NYSE:IQV) on 11/3/2023 |
SBGI Sinclair | $13.30 +4.0% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $30.00 -> $20.00 | Low | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/3/2023 |
W Wayfair | $58.66 +16.1% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $100.00 -> $65.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 11/3/2023 |
STEM Stem | $1.91 +2.7% | 11/3/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Stem (NYSE:STEM) on 11/3/2023 |
GNRC Generac | $128.66 +0.8% | 11/3/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $142.00 | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 11/3/2023 |
CFLT Confluent | $28.17 -0.1% | 11/3/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $23.00 | Low | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 11/3/2023 |
SEDG SolarEdge Technologies | $59.66 +2.7% | 11/2/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/2/2023 |
NRG NRG Energy | $75.13 +2.0% | 11/1/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $50.00 | Low | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 11/1/2023 |
TRML Tourmaline Bio | $15.92 +1.3% | 10/31/2023 | Initiated by | Guggenheim | - | Buy | $50.00 | Low | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 10/31/2023 |
DNTH Dianthus Therapeutics | $24.01 +6.6% | 10/30/2023 | Initiated by | Guggenheim | - | Buy | $45.00 | Low | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/30/2023 |
IDA IDACORP | $95.39 -0.6% | 10/27/2023 | Initiated by | Guggenheim | - | Buy | $104.00 | Low | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 10/27/2023 |
LYV Live Nation Entertainment | $88.27 -1.1% | 10/26/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $124.00 -> $125.00 | Low | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 10/26/2023 |
AKAM Akamai Technologies | $99.74 -1.1% | 10/26/2023 | Upgraded by | Guggenheim | - | Sell -> Neutral | | Low | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 10/26/2023 |
FND Floor & Decor | $112.80 +3.2% | 10/23/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $115.00 -> $95.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 10/23/2023 |
The AI Stock that’s Disrupting Every Industry (Ad) Move over Nvidia. There’s a new hot AI play that has soared 960% in the past year.
One high-flying artificial intelligence stock has soared 960% over the past year and may soon become as familiar as Nvidia… Here's the Ticker >>> |
DT Dynatrace | $45.85 +0.6% | 10/23/2023 | Initiated by | Guggenheim | - | Buy | $58.00 | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 10/23/2023 |
DDOG Datadog | $125.46 -0.8% | 10/23/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 10/23/2023 |
MCD McDonald's | $273.28 -0.4% | 10/19/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $330.00 -> $285.00 | Low | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/19/2023 |
ANIP ANI Pharmaceuticals | $67.11 +0.9% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $72.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 10/19/2023 |
NFLX Netflix | $565.15 +2.4% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $460.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/19/2023 |
TSLA Tesla | $180.01 +0.0% | 10/19/2023 | Reiterated by | Guggenheim | - | Sell -> Sell | $125.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/19/2023 |
NOW ServiceNow | $695.72 +1.5% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $657.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 10/19/2023 |
ROIV Roivant Sciences | $11.24 +0.3% | 10/17/2023 | Initiated by | Guggenheim | - | Buy | $17.00 | Low | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 10/17/2023 |
ES Eversource Energy | $60.75 -1.4% | 10/13/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | $60.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/13/2023 |
EXEL Exelixis | $22.12 +0.9% | 10/11/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/11/2023 |
DIS Walt Disney | $112.62 +1.9% | 10/10/2023 | Target Lowered by | Guggenheim | - | | $125.00 -> $115.00 | Low | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 10/10/2023 |
NMRA Neumora Therapeutics | $9.22 +1.3% | 10/10/2023 | Initiated by | Guggenheim | - | Buy | $22.00 | Low | View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 10/10/2023 |
WEC WEC Energy Group | $83.06 +0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $94.00 -> $84.00 | Low | View details for Guggenheim rating of WEC Energy Group (NYSE:WEC) on 10/9/2023 |
SRE Sempra | $72.88 +1.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $86.00 -> $76.00 | Low | View details for Guggenheim rating of Sempra (NYSE:SRE) on 10/9/2023 |
SR Spire | $61.66 -0.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $65.00 -> $55.00 | Low | View details for Guggenheim rating of Spire (NYSE:SR) on 10/9/2023 |
SO Southern | $75.36 +1.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $80.00 -> $72.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 10/9/2023 |
PPL PPL | $27.91 -0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $31.00 -> $27.00 | Low | View details for Guggenheim rating of PPL (NYSE:PPL) on 10/9/2023 |
POR Portland General Electric | $43.48 -1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $48.00 -> $45.00 | Low | View details for Guggenheim rating of Portland General Electric (NYSE:POR) on 10/9/2023 |
PNW Pinnacle West Capital | $75.04 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $83.00 -> $73.00 | Low | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 10/9/2023 |
PEG Public Service Enterprise Group | $70.02 +0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $70.00 -> $64.00 | Low | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 10/9/2023 |
PCG PG&E | $17.53 +0.7% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $21.00 -> $19.00 | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 10/9/2023 |
OGS ONE Gas | $65.91 +1.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $73.00 -> $64.00 | Low | View details for Guggenheim rating of ONE Gas (NYSE:OGS) on 10/9/2023 |
OGE OGE Energy | $35.03 -0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $36.00 -> $32.00 | Low | View details for Guggenheim rating of OGE Energy (NYSE:OGE) on 10/9/2023 |
NWN Northwest Natural | $38.83 +1.7% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $42.00 -> $37.00 | Low | View details for Guggenheim rating of Northwest Natural (NYSE:NWN) on 10/9/2023 |
NWE NorthWestern Energy Group | $51.00 +0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $48.00 -> $41.00 | Low | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 10/9/2023 |
NJR New Jersey Resources | $44.55 +1.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $47.00 -> $42.00 | Low | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 10/9/2023 |
NI NiSource | $28.49 +1.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $30.00 -> $27.00 | Low | View details for Guggenheim rating of NiSource (NYSE:NI) on 10/9/2023 |
NEE NextEra Energy | $68.86 +0.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $73.00 -> $65.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/9/2023 |
LNT Alliant Energy | $50.85 +1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $49.00 -> $43.00 | Low | View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 10/9/2023 |
FE FirstEnergy | $39.09 +1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $44.00 -> $38.00 | Low | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 10/9/2023 |
EXC Exelon | $37.89 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $45.00 -> $41.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 10/9/2023 |
EVRG Evergy | $53.55 +1.2% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $62.00 -> $54.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/9/2023 |
ETR Entergy | $107.16 +0.2% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $113.00 -> $99.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 10/9/2023 |
ES Eversource Energy | $60.75 -1.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $80.00 -> $70.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/9/2023 |
EIX Edison International | $71.97 +1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $74.00 -> $63.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 10/9/2023 |
ED Consolidated Edison | $95.25 +0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $85.00 -> $82.00 | Low | View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 10/9/2023 |
DUK Duke Energy | $99.30 -0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $102.00 -> $93.00 | Low | View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 10/9/2023 |
DTE DTE Energy | $111.91 +0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $124.00 -> $110.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 10/9/2023 |
D Dominion Energy | $51.16 +0.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $56.00 -> $49.00 | Low | View details for Guggenheim rating of Dominion Energy (NYSE:D) on 10/9/2023 |
CPK Chesapeake Utilities | $109.22 +1.9% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $112.00 -> $99.00 | Low | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 10/9/2023 |
CNP CenterPoint Energy | $29.40 +0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $34.00 -> $29.00 | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 10/9/2023 |
CMS CMS Energy | $61.27 +0.7% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $61.00 -> $54.00 | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 10/9/2023 |
AWK American Water Works | $125.98 +0.7% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $147.00 -> $126.00 | Low | View details for Guggenheim rating of American Water Works (NYSE:AWK) on 10/9/2023 |
AVA Avista | $36.79 +0.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $33.00 -> $26.00 | Low | View details for Guggenheim rating of Avista (NYSE:AVA) on 10/9/2023 |
ALE ALLETE | $60.87 +0.9% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $49.00 -> $41.00 | Low | View details for Guggenheim rating of ALLETE (NYSE:ALE) on 10/9/2023 |
AEP American Electric Power | $88.25 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $96.00 -> $85.00 | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 10/9/2023 |
AEE Ameren | $75.27 +1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $85.00 -> $75.00 | Low | View details for Guggenheim rating of Ameren (NYSE:AEE) on 10/9/2023 |
ARM ARM | 98.00 +2.8% | 10/9/2023 | Initiated by | Guggenheim | - | Buy | 64.00 | Low | View details for Guggenheim rating of ARM (NASDAQ:ARM) on 10/9/2023 |
WBD Warner Bros. Discovery | $7.95 +4.3% | 10/4/2023 | Target Lowered by | Guggenheim | - | | $18.00 -> $15.00 | Low | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 10/4/2023 |
DKNG DraftKings | $43.03 +2.9% | 10/4/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $38.00 -> $37.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/4/2023 |
SNDX Syndax Pharmaceuticals | $21.86 -0.5% | 10/3/2023 | Target Raised by | Guggenheim | - | | $42.00 -> $43.00 | Low | View details for Guggenheim rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 10/3/2023 |
EVRG Evergy | $53.55 +1.2% | 10/3/2023 | Target Lowered by | Guggenheim | - | | $68.00 -> $62.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/3/2023 |
PARA Paramount Global | $13.86 +13.1% | 10/2/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $21.00 -> $19.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 10/2/2023 |
GPCR Structure Therapeutics | $38.99 -0.8% | 10/2/2023 | Target Raised by | Guggenheim | - | | $50.00 -> $92.00 | Low | View details for Guggenheim rating of Structure Therapeutics (NASDAQ:GPCR) on 10/2/2023 |
META Meta Platforms | $441.68 +0.6% | 9/27/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $375.00 -> $380.00 | Low | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 9/27/2023 |
NOVA Sunnova Energy International | $4.32 +22.4% | 9/27/2023 | Target Lowered by | Guggenheim | - | | $30.00 -> $17.00 | Low | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 9/27/2023 |
IMVT Immunovant | $28.78 +0.9% | 9/27/2023 | Target Raised by | Guggenheim | - | | $32.00 -> $48.00 | Low | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 9/27/2023 |
EXEL Exelixis | $22.12 +0.9% | 9/25/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $27.00 -> $30.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 9/25/2023 |
MSFT Microsoft | $397.84 +0.7% | 9/25/2023 | Upgraded by | Guggenheim | - | Sell -> Neutral | | Low | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 9/25/2023 |
IMVT Immunovant | $28.78 +0.9% | 9/22/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $32.00 | Low | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 9/22/2023 |